LBO — UPPER VALLEY MEDICAL CENTER
IRR: 16.5% | MOIC: 2.14x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
16.5%
IRR
2.14x
MOIC
$192.8M
Entry EV
$289.1M
Exit EV
$99.2M
Equity Invested
Sources & Uses
S&UTotal · $192.8M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $74.9M | 38.8% | |
| Sub Debt | $18.7M | 9.7% | |
| Equity | $99.2M | 51.5% | |
| Enterprise Value | $187.2M | 97.1% | |
| Transaction Fees | $5.6M | 2.9% | |
| Total Uses | $192.8M | 100.0% |
Interpretation
INTAt 2.14x MOIC and 16.5% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $27.5M |
| Exit Ev | $289.1M |
| Net Debt At Exit | $76.3M |
| Equity At Exit | $212.7M |
| Equity Invested | $99.2M |
| Total Value Created | $113.5M |
| Value From Growth | $92.5M |
| Value From Multiple | $9.4M |
| Value From Deleveraging | $17.3M |